UBS Group’s STAAR Surgical STAA Stock Holding History

UBS Group’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.18M	Buy	+63,000	New	+$1.2M	﹤0.01%	5426

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Yunqi Capital Hong Kong $92.4M AUM 16.3% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIM

Anatole Investment Management Central, Hong Kong $716M AUM 502.49% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group's STAA Position: Q1 2026 in Review

UBS Group reduced its STAAR Surgical (STAA) stake by 45% in Q1 2026, selling an estimated $2.82M and leaving 179,929 shares worth $3.36M. The position accounts for ﹤0.01% of the portfolio, ranked #4472.

UBS Group first reported a position in STAA in Q4 2014 and has held it in 46 quarters since. The position peaked at $7.57M in Q4 2025. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

UBS Group held 179,929 shares of STAAR Surgical worth $3.36M as of Q1 2026.
UBS Group sold 147,923 STAAR Surgical shares in Q1 2026, an estimated $2.82M.
STAAR Surgical made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4472 holding.
UBS Group first reported a position in STAAR Surgical in Q4 2014 and has held it in 46 quarters since.
UBS Group's STAAR Surgical position peaked at $7.57M in Q4 2025.
187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.